• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性巨细胞病毒感染与机会性感染。肾移植受者中的发病率。

Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients.

作者信息

Chatterjee S N, Fiala M, Weiner J, Stewart J A, Stacey B, Warmer N

出版信息

JAMA. 1978 Nov 24;240(22):2446-9.

PMID:213620
Abstract

Thirty-five renal allograft recipients were studied concerning the relationship between cytomegalovirus (CMV), herpes simplex virus (HSV), and opportunistic bacterial and fungal infections. The incidence of opportunistic infections was determined for patients whose tests prior to transplantation were seronegative in complement fixation and indirect hemagglutination assays of CMV antibody and for those patients whose tests were seropositive. Among the six seronegative patients with seronegative tests, four (66%) experienced active CMV infection within two months, and four died of Candida or Aspergillus infection within six months after transplantation. Among the 22 patients with seropositive tests, only one (4%) had a fungal infection and it was nonfatal (P less than .05). The increased morbidity and mortality due to fungal and bacterial infections in transplant recipients with seronegative CMV tests appears, therefore, to be related to primary CMV infection rather than to generalized immunodeficiency.

摘要

对35例肾移植受者进行了关于巨细胞病毒(CMV)、单纯疱疹病毒(HSV)与机会性细菌和真菌感染之间关系的研究。对移植前在CMV抗体补体结合试验和间接血凝试验中血清学阴性的患者以及血清学阳性的患者确定机会性感染的发生率。在6例血清学阴性的患者中,4例(66%)在两个月内发生活动性CMV感染,4例在移植后6个月内死于念珠菌或曲霉菌感染。在22例血清学阳性的患者中,只有1例(4%)发生真菌感染且非致命性(P小于0.05)。因此,CMV血清学阴性的移植受者因真菌和细菌感染导致的发病率和死亡率增加似乎与原发性CMV感染有关,而非与全身性免疫缺陷有关。

相似文献

1
Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients.原发性巨细胞病毒感染与机会性感染。肾移植受者中的发病率。
JAMA. 1978 Nov 24;240(22):2446-9.
2
[Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].[肾移植受者巨细胞病毒、单纯疱疹病毒和水痘-带状疱疹病毒感染的血清学随访]
G Batteriol Virol Immunol. 1991 Jan-Dec;84(1-12):41-52.
3
Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.巨细胞病毒复制及“疱疹病毒负荷”作为肾移植术后第一年心血管事件的危险因素
Transplant Proc. 2005 Nov;37(9):3760-3. doi: 10.1016/j.transproceed.2005.08.058.
4
Cytomegalo and herpes simplex virus infections in renal transplant recipients.肾移植受者的巨细胞病毒和单纯疱疹病毒感染
Scand J Urol Nephrol Suppl. 1985;92:5-8.
5
Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.小儿心脏移植术后感染:一项多机构研究的结果。小儿心脏移植研究组
J Heart Lung Transplant. 1997 Dec;16(12):1207-16.
6
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.伐昔洛韦预防肾移植后巨细胞病毒病。国际伐昔洛韦预防巨细胞病毒移植研究组。
N Engl J Med. 1999 May 13;340(19):1462-70. doi: 10.1056/NEJM199905133401903.
7
Viral infections in renal transplant donors and their recipients: a prospective study.肾移植供体及其受体中的病毒感染:一项前瞻性研究。
Surgery. 1977 May;81(5):487-92.
8
The effects of viral infections on renal transplants and their recipients.病毒感染对肾移植及其受者的影响。
Q J Med. 1980 Spring;49(194):219-31.
9
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.静脉注射免疫球蛋白和巨细胞病毒血清阴性血液制品用于预防骨髓移植受者的巨细胞病毒感染和疾病。
Bone Marrow Transplant. 1993 Sep;12(3):283-8.
10
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.肾移植受者的巨细胞病毒病:一项关于临床特征、危险因素及对肾移植影响的前瞻性研究
Medicine (Baltimore). 1980 Jul;59(4):283-300.

引用本文的文献

1
Gastroenterological complications in kidney transplant patients.肾移植患者的胃肠并发症
Open Med (Wars). 2020 Jul 11;15(1):623-634. doi: 10.1515/med-2020-0130. eCollection 2020.
2
Resistant pathogens, fungi, and viruses.耐药病原体、真菌和病毒。
Surg Clin North Am. 2014 Dec;94(6):1195-218. doi: 10.1016/j.suc.2014.08.010. Epub 2014 Oct 3.
3
A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients.肾移植受者预防巨细胞病毒感染的预防性策略与抢先性策略的系统评价和荟萃分析
Int J Organ Transplant Med. 2012;3(1):10-7.
4
CMV in critically ill patients: pathogen or bystander?巨细胞病毒在危重症患者中的作用:病原体还是旁观者?
Rev Med Virol. 2010 Nov;20(6):372-9. doi: 10.1002/rmv.664.
5
longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients.肾移植受者中抗BK病毒衣壳蛋白免疫球蛋白水平的纵向分析
Clin Vaccine Immunol. 2008 Oct;15(10):1564-71. doi: 10.1128/CVI.00206-08. Epub 2008 Aug 27.
6
Cytomegalovirus infection and abdominal pain with mycophenolate mofetil: is there a link?巨细胞病毒感染与霉酚酸酯引起的腹痛:有关联吗?
Drug Saf. 2001;24(6):405-12. doi: 10.2165/00002018-200124060-00001.
7
Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.骨髓移植受者的感染及微生物学实验室在临床移植中的作用。
Clin Microbiol Rev. 1997 Apr;10(2):277-97. doi: 10.1128/CMR.10.2.277.
8
The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression.人类巨细胞病毒的立即早期基因上调肿瘤坏死因子-α基因的表达。
J Clin Invest. 1994 Feb;93(2):474-8. doi: 10.1172/JCI116995.
9
Cytomegalovirus infections in renal transplant patients.肾移植患者的巨细胞病毒感染
Int Urol Nephrol. 1994;26(5):587-93. doi: 10.1007/BF02767664.
10
Re: life and death.关于:生与死。
Bull N Y Acad Med. 1980 Jul-Aug;56(6):513-38.